PIOGLITAZON ACTAVIS

15MG TBL NOB 28 KAL

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 21.01.2021
Interruption of marketing 17.09.2020 0193077, 0233298, 0026304
Dle indikací
Manufacturing reasons 30.09.2020
Resumption of marketing 01.10.2019
Interruption of marketing 30.09.2019 0193077, 0026304
Manufacturing reasons Nelze stanovit
Placing on the market 01.06.2012

All reports are available in the Overview.

Back to list